Nexus Pharmaceuticals
  • Home
  • Our Company
    • About Us
    • Focus and Responsibility
    • Commitment to Quality
    • Team and Culture
  • Diverse Supplier
    • Nexus Procurement Services
  • Products
  • Careers
  • News
    • Latest News
    • State-of-the- Art Manufacturing Facility
  • Contact Us
Select Page
Nexus Pharmaceuticals Receives FDA Approval for Potassium Chloride in Water for Injection

Nexus Pharmaceuticals Receives FDA Approval for Potassium Chloride in Water for Injection

by Deana Mndrucic | Mar 28, 2021 | News, Product Approvals

LINCOLNSHIRE, Ill.–Nexus Pharmaceuticals announced today that it has received U.S. Food and Drug Administration (FDA) approval for Potassium Chloride in Water for Injection in 10mEq/100mL, 10mEq/50mL, 20mEq/100mL, 40mEq/100mL and 20mEq/50mL Single-Dose IV bags....
Nexus Pharmaceuticals Announces Verbal to Occupy Authorization

Nexus Pharmaceuticals Announces Verbal to Occupy Authorization

by Deana Mndrucic | Mar 23, 2021 | News

LINCOLNSHIRE, Ill.–Nexus Pharmaceuticals, Inc. is pleased to announce that it has received authorization to occupy its new pharmaceutical manufacturing facility from the Village of Pleasant Prairie, Wisconsin. Nexus Pharmaceuticals, which specializes in...
Nexus Pharmaceuticals Discusses COVID-19 Response in BioForward Webinar

Nexus Pharmaceuticals Discusses COVID-19 Response in BioForward Webinar

by Deana Mndrucic | Jan 27, 2021 | News

PLEASANT PRAIRIE, WI.–Nexus Pharmaceuticals Chief Strategy Officer, Omair Ahmed, joined nine BioForward member organizations in a discussion regarding the Wisconsin biohealth industry’s response to the COVID-19 pandemic. “We pride ourselves in...
Nexus Pharmaceuticals Discusses COVID-19 Response in BioForward Webinar

Nexus Pharmaceuticals sets month for $100M plant opening, preps drug for treating Covid patients

by Deana Mndrucic | Dec 21, 2020 | News

PLEASANT PRAIRIE, WI.–Nexus Pharmaceuticals Inc. plans to complete its nearly $100 million Pleasant Prairie sterile injectables plant in April 2021 and a company executive said it will help address the United States’ reliance on foreign pharmaceutical suppliers...
Nexus Pharmaceuticals Discusses COVID-19 Response in BioForward Webinar

Nexus Pharmaceuticals Announces Diversity Certification

by Deana Mndrucic | Dec 3, 2020 | News

LINCOLNSHIRE, Ill.–Nexus Pharmaceuticals is pleased to announce their continuous certification as a Minority Business Enterprise (MBE) and a Women’s Business Enterprise (WBE). The diversity-based certifications, appointed by the National Minority Supplier...
« Older Entries
© 2022 Nexus Pharmaceuticals, Inc.
  • Du kan l sa mer om tj nsten p v r hemsida.
  • Farmaci per l'Impotenza
  • In some embodiments of formula (I), R 3 is selected from.
  • No pathological signs were noted during necropsy.
  • Og oftest er disse m nd helt ude af balance her.
  • Quindi, tenete gli occhi aperti!
  • Un traitement quotidien contre l'impuissance
  • What is Tocilizumab (Actemra®)?